Recent Finacing
Recent Raise
Freeline is a clinical-stage biotech developing liver-targeted AAV gene therapies, advancing Hemophilia B to pivotal, with Phase 1/2 Fabry plus Gaucher and HemA programs, expanding next-gen AAV manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
